The FINANCIAL — Novo Nordisk on September 16 announced that the Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion to extend the use of NovoRapid (insulin aspart) in ...
Diabetes rates are rising. Recent data suggesting close to five million people have the condition which affects how someone’s body manages their blood sugar levels. As patient numbers rise, the number ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin Aspart (Novorapid Flexpen Vial) is a fast ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor, diabetes education nurse, or pharmacist. NovoRapid ® contains the active ingredient ...
Insulin Lispro (Novorapid Flexpen (100 iu)) is a fast acting insulin analogue, prescribed for type 1 diabetes. The information provided on this page is intended to serve as a comprehensive resource ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor, diabetes education nurse, or pharmacist. NovoRapid ® contains the active ingredient ...
Bagsværd, Denmark, 4 December 2015 - Novo Nordisk today announced the submission to the European Medicines Agency of the Marketing Authorisation Application (MAA) for the approval of faster-acting ...
"Soon, having the production line of Novorapid insulin completed and launched in the country, Iran can stop imports and start exports of the product," he tweeted. As he added, Iran spends a huge ...
Bagsværd, Denmark, 25 March 2015 - Novo Nordisk today announced headline results from the final phase 3a trials for faster-acting insulin aspart, onset ® 1 and onset ® 2. The trials investigated the ...
This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announces the European Medicines Agency (EMA) marketing ...
"NovoRapid ® has a long, proven safety and efficacy profile for the treatment of diabetes in adults, adolescents and children. The positive CHMP opinion for the extended use of NovoRapid ® in children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results